Veracyte (NASDAQ:VCYT) Now Covered by Analysts at UBS Group
UBS Group initiated coverage on shares of Veracyte (NASDAQ:VCYT – Free Report) in a report published on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $43.00 price objective on the biotechnology company’s stock. Several other research analysts have also commented on VCYT. Morgan Stanley boosted their price objective on shares […]
More Stories
New Century Financial Group LLC Grows Position in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA)
New Century Financial Group LLC lifted its holdings in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 13.9%...
Means Investment CO. Inc. Has $6.09 Million Stake in Oracle Co. (NYSE:ORCL)
Means Investment CO. Inc. lifted its stake in shares of Oracle Co. (NYSE:ORCL – Free Report) by 1.4% in the...
Pfizer Inc. (NYSE:PFE) Shares Sold by CNB Bank
CNB Bank lowered its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 3.5% during the third quarter,...
The Coca-Cola Company (NYSE:KO) Shares Sold by CNB Bank
CNB Bank lowered its position in The Coca-Cola Company (NYSE:KO – Free Report) by 4.0% in the third quarter, according...
Alta Wealth Advisors LLC Sells 8,909 Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD)
Alta Wealth Advisors LLC lowered its position in Advanced Micro Devices, Inc. (NASDAQ:AMD – Free Report) by 59.5% during the...
Chevron Co. (NYSE:CVX) Shares Bought by Schaper Benz & Wise Investment Counsel Inc. WI
Schaper Benz & Wise Investment Counsel Inc. WI lifted its position in shares of Chevron Co. (NYSE:CVX – Free Report)...